Holen Sie sich die Stockscreener-App
58.21
2.71%
-1.62
Schlusskurs vom Vortag:
$59.83
Offen:
$59.87
24-Stunden-Volumen:
623.95K
Relative Volume:
0.39
Marktkapitalisierung:
$8.41B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-946.53M
KGV:
-8.3558
EPS:
-6.9664
Netto-Cashflow:
$-814.94M
1W Leistung:
-0.31%
1M Leistung:
+28.16%
6M Leistung:
+26.41%
1J Leistung:
+60.62%
1-Tages-Spanne:
$56.65
$59.91
1-Wochen-Bereich:
$56.55
$61.77
52-Wochen-Spanne:
$29.08
$65.00
Vaxcyte Inc Stock (PCVX) Company Profile
Firmenname
Vaxcyte Inc
Sektor
Branche
Telefon
650-837-0111
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
58.21 | 8.41B | 0 | -946.53M | -814.94M | -6.9664 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Bestätigt | Needham | Buy |
| 2025-09-12 | Eingeleitet | Goldman | Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Eingeleitet | Goldman | Buy |
| 2023-12-07 | Eingeleitet | Mizuho | Buy |
| 2023-04-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-03 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | Guggenheim | Buy |
| 2022-11-17 | Eingeleitet | BTIG Research | Buy |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-06-24 | Fortgesetzt | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Why (PCVX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Vaxcyte to Participate in Upcoming Investor Conferences - Investing News Network
Vaxcyte Inc develops next-generation vaccines as interest in pneumococcal prevention grows - ad-hoc-news.de
Should Early VAX-A1 Trial Progress Require Action From Vaxcyte (PCVX) Investors? - simplywall.st
Vaxcyte COO Jim Wassil sells $126,736 in PCVX shares By Investing.com - Investing.com Australia
Vaxcyte president and CFO sells $572k in company stock By Investing.com - Investing.com Australia
Vaxcyte president and CFO sells $572k in company stock - Investing.com
Form 4 Vaxcyte Inc For: 6 July By Investing.com - Investing.com Nigeria
[Form 4] Vaxcyte, Inc. Insider Trading Activity - Stock Titan
Vaxcyte COO Jim Wassil sells $126,736 in PCVX shares - Investing.com
Vaxcyte (PCVX) COO logs 2,250-share sale and option exercise in Form 4 - Stock Titan
Affiliate plans 10,000-share sale by option exercise — PCVX - Stock Titan
Vaxcyte, Inc. (PCVX) Stock Analysis: Biotechnology Innovator with an 86.68% Potential Upside - DirectorsTalk Interviews
PCVXVaxcyte Inc Volatility & Greeks - Finviz
Vaxcyte stock stays tied to pipeline progress. Nasdaq listing and SEC filings frame the setup. - ad-hoc-news.de
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now - Yahoo Finance
Have Insiders Sold Vaxcyte Shares Recently? - simplywall.st
Form 144 Vaxcyte For: 1 July By Investing.com - Investing.com Canada
PCVX (NASDAQ) director reported three 2,250-share sales and RSU/option items - Stock Titan
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Growth Benchmark - marketscreener.com
10 Health Care Stocks With Whale Alerts In Today’s Session - Benzinga
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2000 Growth Benchmark - marketscreener.com
Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 92.85% Upside in the Biotech Sector - DirectorsTalk Interviews
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 3000E Growth Benchmark - marketscreener.com
Vaxcyte Insider Sold Shares Worth $1,338,270, According to a Recent SEC Filing - marketscreener.com
Is Vaxcyte’s (PCVX) Russell Index Debut Quietly Reframing Its Long‑Term Governance And Growth Story? - simplywall.st
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Understanding Momentum Shifts in (PCVX) - Stock Traders Daily
Enterprise value to EBIT forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Price to book forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Enterprise value to EBIT forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Price to sales forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Enterprise value to revenue forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Price to earnings forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Enterprise value to EBITDA forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Price to earnings forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Price to book forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Vaxcyte CEO Grant Pickering sells $1.34m in company shares By Investing.com - Investing.com India
Vaxcyte CEO Grant Pickering sells $1.34m in company shares - Investing.com UK
Form 144 Vaxcyte For: 26 June By Investing.com - Investing.com South Africa
Form 4 Vaxcyte Inc For: 26 June By Investing.com - Investing.com Nigeria
Vaxcyte (PCVX) CEO and family trusts sell 24,237 shares under 10b5-1 plan - Stock Titan
PCVX Forecast — Price Target — Prediction for 2027 - TradingView
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):